Клінічні характеристики та застосування статинів у пацієнтів зі стабільною ішемічною хворобою серця при скеруванні для виконання ангіографії або аортокоронарного шунтування

І.В. Шклянка, О.Й. Жарінов, К.О. Міхалєв, О.А. Єпанчінцева

Література 

1. Caorsi C, Pineda F, Munoz C. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. Eur Cytokine Netw. 2008;19(2):99-103.
2. De Waal BA, Buise MP, Van Zundert AAJ. Perioperative Statin Therapy in Patients at High Risk for Cardiovascular Morbidity Undergoing Surgery. Br J Anaesth. 2015;114(1):44-52.
3. ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2016;37:2999-3058.
4. Filion KB, Pilote L, Rahme E. et al. Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery. J Card Surg. 2008;23:209-215.
5. Hernández-Díaz Y, Tovilla-Zárate CA, Juárez-Rojop I. et al. The role of gene variants of the inflammatory markers CRP and TNF-α in cardiovascular heart disease: systematic review and meta-analysis. Int J Clin Exp Med. 2015;8(8):11958-11984.
6. Kang S, Liu Y, Liu XB. Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials. Clin Ther. 2013;35(8):1125-1136.
7. Кrivoy N, Adler Z, Saloma R. et al. Targeting C-reactive protein levels using high-dose atorvastatin before coronary artery bypass graft surgery. Exp Clin Cardiol. 2008;13(4):171-174.
8. Kuhn EW, Slottosch I, Wahlers T, Liakopoulos OJ. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Systematic Reviews. 2015;8. CD008493.
9. Kulik A, Brookhart MA, Levin R. et al. Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery. Circulation. 2008;118:1785-1792.
10. Kulik A, Ruel M, Jneid H. Secondary prevention after coronary artery bypass graft surgery. A Scientific Statement from the American Heart Association. Circulation. 2015;10:927-964.
11. Kulik A, Voisine P, Mathieu P. et al. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial. Ann Thorac Surg. 2011;92 (4):1284-1290.
12. Liakopoulos OJ, Choi YH, Haldenwang PL. et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30 000 patients. Eur Heart J. 2008;29 (12):1548-1559.
13. Loppnow H, Zhang L, Buerke M et al. Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures. J Cell Mol Med. 2011;15 (4):994-1004.
14. Mills EJ, Wu P, Chong G et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM. 2011;104 (2):109-124.
15. Montalescot G, Sechtem U, Achenbach S. et al. 2013 ESC guidelines on the management of stable coronary artery disease.The task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003.
16. Ozaydin M, Dogan A, Varol E. et al. Statin use before bypass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology. 2007;107:117-121.
17. Pan W, Collard C.D, Coselli J. et al. Effect of Dose and Timing of Preoperative Statins on Mortality After Coronary Artery Bypass Surgery. Ann. Thor. Surgery. 2017 Mar 15. pii: S0003-4975(17)30016-4. doi: 10.1016/j.athoracsur.2016.12.043. [Epub ahead of print].
18. Patti G, Chello M, Candura D. et al. Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3. Circulation. 2006;114:145-146.
19. Riley P, Sudarshi D, Johal M. et al. Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study. Int J Clin Pract. 2008;62:374-381.
20. Stone NJ, Robinson JG, Lichtenstein AH et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2889-2934.
21. Taylor F, Huffman MD, Macedo AF. et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2013. Jan 31 (1). CD004816. doi: 10.1002/14651858.CD004816.pub5.
22. Wahre T, Yundestat A, Smith C et al. Increased Expression of Interleukin-1 in Coronary Artery Disease With Downregulatory Effects of HMG-CoA Reductase Inhibitors. Circulation. 2004;109(16):1966-1972.

 

[PDF] [Зміст журналу]